Bruker Corporation provided earnings guidance for fiscal year of 2022. The Company now expects approximately 5% to 7% year-over-year revenue growth, including organic revenue growth of approximately 6% to 8%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.94 USD | +0.09% | -0.35% | +27.84% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.84% | 12.92B | |
+9.50% | 221B | |
+7.95% | 184B | |
+18.30% | 142B | |
+18.47% | 101B | |
+7.83% | 68.07B | |
+25.32% | 57.27B | |
-3.69% | 47.42B | |
+4.66% | 43.19B | |
+15.12% | 28.84B |
- Stock
- Equities
- Stock Bruker Corporation - Nasdaq
- News Bruker Corporation
- Bruker Corporation Provides Earnings Guidance for Fiscal Year of 2022